Insider Stock Trading History of Vaishnaw Akshay


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Vaishnaw Akshay since year 2005. The trader's CIK number is 1458494. At the time of this reporting, Vaishnaw Akshay is the EVP, R&D of Alnylam Pharmaceuticals, Inc. . (stock ticker symbol ALNY). See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Vaishnaw Akshay since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-13 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 1,668 20.00 33,368
2017-05-23 ALNY Alnylam Pharmaceuticals, Inc. Sale 11,000 75.00 825,000
2017-05-23 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 11,000 21.35 234,850
2017-05-15 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 43,750 26.37 1,153,687
2017-05-15 ALNY Alnylam Pharmaceuticals, Inc. Sale 43,750 65.00 2,843,750
2016-12-30 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 9,547 18.81 179,607
2016-11-30 ALNY Alnylam Pharmaceuticals, Inc. Sale 29,165 45.34 1,322,457
2016-11-30 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 29,165 22.75 663,503
2015-11-25 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 5,750 19.59 112,642
2015-06-16 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 8,750 8.20 71,750
2015-06-16 ALNY Alnylam Pharmaceuticals, Inc. Sale 8,750 129.49 1,132,993
2015-03-17 ALNY Alnylam Pharmaceuticals, Inc. Sale 8,750 117.30 1,026,410
2015-03-17 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 8,750 8.20 71,750
2014-12-16 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,626 8.51 90,459
2014-12-16 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,626 93.32 991,650
2014-09-16 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,625 8.51 90,450
2014-09-16 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,625 72.21 767,231
2014-06-17 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,625 8.51 90,450
2014-06-17 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,625 69.65 739,999
2014-03-18 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 32,769 9.62 315,401
2014-03-18 ALNY Alnylam Pharmaceuticals, Inc. Sale 32,769 74.19 2,431,230
2014-01-24 ALNY Alnylam Pharmaceuticals, Inc. Sale 7,890 86.10 679,305
2013-12-16 ALNY Alnylam Pharmaceuticals, Inc. Sale 15,000 60.48 907,215
2013-12-17 ALNY Alnylam Pharmaceuticals, Inc. Sale 18,480 60.99 1,127,169
2013-12-16 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 15,000 8.51 127,695
2013-12-17 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 18,480 12.96 239,500
2013-09-10 ALNY Alnylam Pharmaceuticals, Inc. Sale 6,250 57.78 361,150
2013-09-10 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 6,250 9.30 58,125
2013-06-11 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 15,000 8.51 127,695
2013-06-11 ALNY Alnylam Pharmaceuticals, Inc. Sale 15,000 31.24 468,615
2013-03-11 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 6,250 9.30 58,125
2013-03-11 ALNY Alnylam Pharmaceuticals, Inc. Sale 6,250 24.55 153,412
2012-12-10 ALNY Alnylam Pharmaceuticals, Inc. Sale 4,777 17.00 81,209
2012-12-10 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 4,777 7.10 33,916
2012-12-12 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,000 19.00 190,000
2012-12-12 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,000 9.22 92,200
2012-12-04 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 2,400 7.10 17,040
2012-12-04 ALNY Alnylam Pharmaceuticals, Inc. Sale 2,400 17.04 40,896
2012-11-30 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 2,823 7.10 20,043
2012-11-30 ALNY Alnylam Pharmaceuticals, Inc. Sale 2,823 17.03 48,072
2012-09-12 ALNY Alnylam Pharmaceuticals, Inc. Sale 4,916 19.00 93,404
2012-09-12 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 4,916 9.30 45,718
2012-09-10 ALNY Alnylam Pharmaceuticals, Inc. Sale 1,334 19.00 25,346
2012-09-10 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 1,334 9.30 12,406
2012-07-16 ALNY Alnylam Pharmaceuticals, Inc. Sale 36,250 19.00 688,750
2012-07-16 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 36,250 9.22 334,225

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vaishnaw Akshay (EVP, R&D of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.